1. Zhao, J-Q, Li, X-N, Fu, L-P, Zhang, N, Cai, J-H. . ISOC1 promotes the proliferation of gastric cancer cells by positively regulating CDK19. In European review for medical and pharmacological sciences, 24, 11602-11609. doi:10.26355/eurrev_202011_23803. https://pubmed.ncbi.nlm.nih.gov/33275227/
2. Gao, Bo, Zhao, Lianmei, Wang, Feifei, Cao, Jian, Wang, Guiying. . Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway. In Carcinogenesis, 41, 1123-1133. doi:10.1093/carcin/bgz188. https://pubmed.ncbi.nlm.nih.gov/31740942/
3. Xiang, Jiao, Gao, Xiao-Qiang, Chen, Xiang-Ling, Lu, Yin-Ying. 2021. ISOC1 is a novel potential tumor suppressor in hepatocellular carcinoma. In Neoplasma, 69, 174-182. doi:10.4149/neo_2021_210815N1157. https://pubmed.ncbi.nlm.nih.gov/34846160/
4. Kushnareva, Yulia, Mathews, Ian T, Andreyev, Alexander Y, Peters, Bjoern, Sharma, Sonia. 2021. Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production. In Journal of immunology (Baltimore, Md. : 1950), 206, 1181-1193. doi:10.4049/jimmunol.2000672. https://pubmed.ncbi.nlm.nih.gov/33547171/
5. Sveinbjornsson, Gardar, Benediktsdottir, Bara D, Sigfusson, Gunnlaugur, Arnar, David O, Stefansson, Kari. 2023. Screening for Rare Coding Variants That Associate With the QTc Interval in Iceland. In Journal of the American Heart Association, 12, e029845. doi:10.1161/JAHA.123.029845. https://pubmed.ncbi.nlm.nih.gov/37449562/
6. Yamaga, Ryonosuke, Ikeda, Kazuhiro, Boele, Joost, de Hoon, Michiel, Inoue, Satoshi. 2014. Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping. In Biochemical and biophysical research communications, 447, 531-6. doi:10.1016/j.bbrc.2014.04.033. https://pubmed.ncbi.nlm.nih.gov/24746470/